146 related articles for article (PubMed ID: 8575426)
1. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.
Buechler YJ; Sosnowski BA; Victor KD; Parandoosh Z; Bussell SJ; Shen C; Ryder M; Houston LL
Eur J Biochem; 1995 Dec; 234(3):706-13. PubMed ID: 8575426
[TBL] [Abstract][Full Text] [Related]
2. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin.
Lappi DA; Matsunami R; Martineau D; Baird A
Anal Biochem; 1993 Aug; 212(2):446-51. PubMed ID: 8214586
[TBL] [Abstract][Full Text] [Related]
3. Biological and chemical characterization of basic FGF-saporin mitotoxin.
Lappi DA; Martineau D; Baird A
Biochem Biophys Res Commun; 1989 Apr; 160(2):917-23. PubMed ID: 2541718
[TBL] [Abstract][Full Text] [Related]
4. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin.
McDonald JR; Ong M; Shen C; Parandoosh Z; Sosnowski B; Bussell S; Houston LL
Protein Expr Purif; 1996 Aug; 8(1):97-108. PubMed ID: 8812840
[TBL] [Abstract][Full Text] [Related]
5. In vivo inhibition of lens regrowth by fibroblast growth factor 2-saporin.
Behar-Cohen FF; David T; D'Hermies F; Pouliquen YM; Buechler Y; Nova MP; Houston LL; Courtois Y
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2434-48. PubMed ID: 7591633
[TBL] [Abstract][Full Text] [Related]
6. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
Lappi DA; Maher PA; Martineau D; Baird A
J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
[TBL] [Abstract][Full Text] [Related]
7. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
Tetzke TA; Caton MC; Maher PA; Parandoosh Z
Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
[TBL] [Abstract][Full Text] [Related]
8. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.
Lappi DA; Ying W; Barthelemy I; Martineau D; Prieto I; Benatti L; Soria M; Baird A
J Biol Chem; 1994 Apr; 269(17):12552-8. PubMed ID: 8175664
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
Miller K; Wilder PJ; Rizzino A
Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
[TBL] [Abstract][Full Text] [Related]
11. Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae).
Ferreras JM; Barbieri L; Girbés T; Battelli MG; Rojo MA; Arias FJ; Rocher MA; Soriano F; Mendéz E; Stirpe F
Biochim Biophys Acta; 1993 Oct; 1216(1):31-42. PubMed ID: 8218413
[TBL] [Abstract][Full Text] [Related]
12. Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers.
Flavell DJ; Boehm DA; Okayama K; Kohler JA; Flavell SU
Int J Cancer; 1994 Aug; 58(3):407-14. PubMed ID: 7519586
[TBL] [Abstract][Full Text] [Related]
13. Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor.
Gonzalez AM; Lappi DA; Buscaglia ML; Carman LS; Gage FH; Baird A
Ann N Y Acad Sci; 1991; 638():442-4. PubMed ID: 1664696
[No Abstract] [Full Text] [Related]
14. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
Ying W; Martineau D; Beitz J; Lappi DA; Baird A
Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of basic fibroblast growth factor-saporin mitotoxin on keratocytes in culture.
Wee WR; Parandoosh Z; Sakamoto T; Caton M; Nova M; McDonnell PJ
Korean J Ophthalmol; 1996 Jun; 10(1):1-7. PubMed ID: 8755195
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease.
Lappi DA; Martineau D; Maher PA; Florkiewicz RZ; Buscaglia M; Gonzalez AM; Farris J; Hamer M; Fox R; Baird A
J Hand Surg Am; 1992 Mar; 17(2):324-32. PubMed ID: 1314273
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a saporin isoform with lower ribosome-inhibiting activity.
Fabbrini MS; Rappocciolo E; Carpani D; Solinas M; Valsasina B; Breme U; Cavallaro U; Nykjaer A; Rovida E; Legname G; Soria MR
Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):719-27. PubMed ID: 9148741
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor-saporin mitotoxin. In vitro studies of its cell-killing activity and of substances that alter that activity.
Martineau D; Lappi DA; Amburn E; Baird A
Ann N Y Acad Sci; 1991; 638():438-41. PubMed ID: 1785818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
